Similar articles

• Effects of 2,2'-dibromobiphenyl and 2,2',3,4,4',5,5'-heptabromobiphenyl on liver microsomal drug metabolizing enzymes.

  Moore RW, Sleight SD, Aust SD. Moore RW, et al. Toxicol Appl Pharmacol. 1979 Mar 30;48(1 Pt 1):73-86. doi: 10.1016/s0041-008x(79)80010-1. Toxicol Appl Pharmacol. 1979. PMID: 222013 No abstract available.
• A comparison of a commercial polybrominated biphenyl mixture, 2,4,5,2',4',5'-hexabromobiphenyl and 2,3,6,7-tetrabromonaphthalene as inducers of liver microsomal drug-metabolizing enzymes.

  Goldstein JA, Linko PC, Levy LA, McKinney JD, Gupta BN, Moore JA. Goldstein JA, et al. Biochem Pharmacol. 1979 Oct 1;28(19):2947-56. doi: 10.1016/0006-2952(79)90591-4. Biochem Pharmacol. 1979. PMID: 229864 No abstract available.
• Induction of drug-metabolizing enzymes by fractionated commercial polybrominated biphenyls (PBBs).

  Robertson L, Parkinson A, Safe S. Robertson L, et al. Toxicol Appl Pharmacol. 1981 Feb;57(2):254-62. doi: 10.1016/0041-008x(81)90287-8. Toxicol Appl Pharmacol. 1981. PMID: 6261418 No abstract available.
• 2,4,5,3',4',5'-Hexabromobiphenyl is both a 3-methylcholanthrene-and a phenobarbital-type inducer of microsomal drug metabolizing enzymes.

  Dannan GA, Moore RW, Besaw LC, Aust SD. Dannan GA, et al. Biochem Biophys Res Commun. 1978 Nov 14;85(1):450-8. doi: 10.1016/s0006-291x(78)80063-1. Biochem Biophys Res Commun. 1978. PMID: 217380 No abstract available.
• Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs.

  Perucca E. Perucca E. Pharmacol Ther. 1987;33(1):139-44. doi: 10.1016/0163-7258(87)90042-8. Pharmacol Ther. 1987. PMID: 3306715 Review. No abstract available.